Dr Michael Hemann

michaelhemann

MIT Department of Technology

Dr. Michael T. Hemann, M.D., Ph.D. serves as the Eisen and Chang Career Development Associate Professor of Biology at the Massachusetts Institute of Technology ( MIT"). Dr. Hemann has expertise in modeling therapeutic resistance in order to identify new drug targets where inhibition can synergize with existing therapies. His laboratory uses RNAi to study the roles of cancer relevant genes in mediating sensitivity and resistance to chemotherapeutic agents. He focused on understanding the role of genetic instability on acquired and intrinsic drug resistance. Dr. Hemann has been a Member of Scientific Advisory Board of Therapeutics at MetaStat, Inc. since February 4, 2012.

Organising Committee

Michelle Haber (Chair)   
Kiri Collins
Tony Phillips    
Maria Kavallaris
Carol Wadham    
Liz Wynn    
David Ziegler    
Greg Arndt
Jessica Keath
Murray Norris
Amanda Philp
Peter Wejbora
Denise Yu
Maree Overall (ASN Events)

Program Committee

Maria Kavallaris (Chair)
Michelle Haber
Richard Lock
Glenn Marshall
Amanda Philp
Toby Trahair   
David Ziegler
Jenny Byrne (SCHN)
Phil Hogg (UNSW)
Debbie Marsh (USYD)
Clare Scott (WEHI)
Alex Swarbrick (Garvan)   
Nikki Verrills (HMRI/UON)
Jamie Fletcher
Tao Liu
Karen MacKenzie
Murray Norris
Rosemary Sutton
Peter Wejbora
Tracy Bryan (CMRI)
Peter Gunning (UNSW)
Lisa Horvath (Lighthouse)
Grant McArthur (Peter Mac)
Ian Street (WEHI)
Mathew Vadas (Centenary)
Maree Overall (ASN)